1. Home
  2. RCEL vs LE Comparison

RCEL vs LE Comparison

Compare RCEL & LE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCEL
  • LE
  • Stock Information
  • Founded
  • RCEL N/A
  • LE 1963
  • Country
  • RCEL United States
  • LE United States
  • Employees
  • RCEL N/A
  • LE N/A
  • Industry
  • RCEL Medical/Dental Instruments
  • LE Clothing/Shoe/Accessory Stores
  • Sector
  • RCEL Health Care
  • LE Consumer Discretionary
  • Exchange
  • RCEL Nasdaq
  • LE Nasdaq
  • Market Cap
  • RCEL 308.6M
  • LE 357.5M
  • IPO Year
  • RCEL N/A
  • LE N/A
  • Fundamental
  • Price
  • RCEL $9.75
  • LE $11.30
  • Analyst Decision
  • RCEL Buy
  • LE Strong Buy
  • Analyst Count
  • RCEL 5
  • LE 2
  • Target Price
  • RCEL $17.25
  • LE $20.00
  • AVG Volume (30 Days)
  • RCEL 191.4K
  • LE 81.0K
  • Earning Date
  • RCEL 02-13-2025
  • LE 03-26-2025
  • Dividend Yield
  • RCEL N/A
  • LE N/A
  • EPS Growth
  • RCEL N/A
  • LE N/A
  • EPS
  • RCEL N/A
  • LE N/A
  • Revenue
  • RCEL $64,251,000.00
  • LE $1,436,124,000.00
  • Revenue This Year
  • RCEL $62.11
  • LE N/A
  • Revenue Next Year
  • RCEL $31.19
  • LE $1.97
  • P/E Ratio
  • RCEL N/A
  • LE N/A
  • Revenue Growth
  • RCEL 28.14
  • LE N/A
  • 52 Week Low
  • RCEL $7.51
  • LE $7.64
  • 52 Week High
  • RCEL $18.93
  • LE $19.88
  • Technical
  • Relative Strength Index (RSI)
  • RCEL 50.10
  • LE 35.22
  • Support Level
  • RCEL $8.37
  • LE $11.15
  • Resistance Level
  • RCEL $11.25
  • LE $11.97
  • Average True Range (ATR)
  • RCEL 0.55
  • LE 0.44
  • MACD
  • RCEL 0.22
  • LE 0.01
  • Stochastic Oscillator
  • RCEL 47.92
  • LE 26.98

About RCEL Avita Medical Inc.

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.

About LE Lands' End Inc.

Lands' End Inc is a United States-based multi-channel retailer of casual clothing, accessories, and footwear, as well as home products. The company's operating segment includes U.S. eCommerce; International; Outfitters; Third Party and Retail. It generates maximum revenue from the U.S. eCommerce segment. The U.S. eCommerce segment offers products through the company's eCommerce website. Geographically, it derives a majority of its revenue from the United States.

Share on Social Networks: